Company Short-Term Debt: anbio.com (NNNN)

Public company logo of Anbio (NNNN)

Anbio Biotechnology management is effectively optimizing logistics and quality control. Partnerships with universities and distributors are helping to implement new tests in new markets. Total short-term debt reflects the dynamics of current liabilities, where 0.00 represents the current metric. The business is currently focusing on aggressive capture of the B2B segment through affordable portable rapid diagnostic systems.

NNNN (Anbio) Company Short-Term Debts history from 02/20/2025 to 10/30/2026

Analytical breakdowns and data insights for company Anbio Corp (NNNN)

- stock price and consensus target price:
Stock Price Anbio|NNNN - Analyst Consensus Forecast
- company stock exchange capitalization indicators:
Market Value Anbio|NNNN - Business Value
- shareholders' equity book value data:
Book Value per Share Anbio Biotechnology|NNNN - Book Capitalization|Market Value to Book Value Ratio anbio.com|NNNN - Aggregate Company Assets
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Anbio Biotechnology|NNNN - Long-Term Liabilities to Capital|Short-Term Debt to Equity Anbio Biotechnology|NNNN - Company Total Debt Obligations|Debts to Book Capitalization Anbio|NNNN - Long-Term Debt Volume|Company Short-Term Debt Anbio Biotechnology|Quick Ratio anbio.com
- net income and valuation multiples indicators:
NNNN - Net Profit
Fundamental company analysis:Anbio (NNNN)
Flagship merchandise of Anbio Biotechnology

The expansion of Anbio Biotechnology (NNNN) within the portable diagnostics segment requires significant working capital to scale rapid testing. An analysis of short-term financial liabilities allows for the tracking of obligations under one year, revealing hidden intra-period spikes in borrowing. A decrease in this metric confirms high liquidity and business resilience, which directly reduces default risk and optimizes the company's overall cost of capital.

Competitors of Anbio Biotechnology

Agilent - Company Short-Term Debts|DGX - Company Short-Term Debts|Illumina Corp (ILMN) - Company Short-Term Debt|Company Short-Term Indebtedness EXAS|RVTY (Revvity, Inc.) - Company Short-Term Debts|Company Short-Term Debts bio-rad.com|Company Short-Term Debt Sotera Health (SHC)|Company Short-Term Debt QDEL (Quidel Corporation)|OPKO Corp - Company Current Liabilities|CareDx (CDNA) - Short-Term Debt|MRVI - Company Short-Term Debt|Short-Term Debt Volume fulgentgenetics.com FLGT|LAB: Company Short-Term Debts|CTKB - Short-Term Debt Volume|Company Short-Term Debt OraSure Technologies Inc|Exagen Diagnostics (XGN) - Short-Term Debt Volume|Company Short-Term Debts MDXH|Company Short-Term Debts luciddx.com (LUCD)|Company Short-Term Debt Prenetics PRE|IMDX: Company Short-Term Indebtedness|Trinity Biotech Corp - Company Short-Term Debts|PRPH: Company Short-Term Debt|AIMD: Company Short-Term Debts|CODX - Short-Term Debt Volume|Company Short-Term Debt HeartSciences|Short-Term Debt Biomerica Inc. BMRA|Company Current Liabilities CDIO (Cardio Diagnostics)|VRAX (Virax Biolabs Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BJDX (Bluejay Diagnostics)|aspirawh.com - Company Short-Term Debt|Accelerate Diagnostics, Inc. - Company Short-Term Debts|Short-Term Debt Volume CENTOGENE N.V. CNTG|enzo.com (ENZ) - Company Short-Term Debt|Short-Term Debt Fresh2 Group (FRES)|Company Current Liabilities GENE|ME (23andme.com) - Amount of Current Liabilities|Company Short-Term Debts PMD